Ionis Pharmaceuticals, Inc. (IONS)
85.45
+0.85
(+1.00%)
USD |
NASDAQ |
Feb 24, 16:00
85.45
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -0.805 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Twist Bioscience Corp. | -0.4995 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Cytokinetics, Inc. | -2.552 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.61M |
| Revenue (Quarterly) | 156.72M |
| Total Expenses (Quarterly) | 285.32M |
| Enterprise Value | 13.65B |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -82.06% |
| Earnings Yield | -2.00% |
| Normalized Earnings Yield | -2.049 |